
    
      The purpose of this study is to evaluate the safety and pharmacokinetics of tofacitinib after
      single oral administration of Xeljanz tab. 5mg as reference drug and HL-TOF tab. 5mg as test
      drug in healthy voluteers. AUC and Cmax would be evaluated for the pharmacokinetics. Adverse
      event, Laboratory examination and other examination result would be evaluated for the safety.
    
  